Plozalizumab (Anti-CCR2 / CD192)

Ask supplier a question | View on supplier's website

Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2569
Sku #	A2569-1mg*25
Pricing	1mg*25, $5070.00

Feedback